top of page


Nanotrap® Microbiome A Particles capture and concentrate viruses prior to nucleic acid extraction, in order to improve detection of those viruses in downstream analytical methods.

Application Highlights

  • Nanotrap® Microbiome Particles enable simple, automated methods for respiratory viruses, such as influenza and SARS-CoV-2, in transport medium samples

  • Nanotrap Microbiome Particles capture and concentrate whole viruses and can be used with a wide range of nucleic acid extraction kits.

  • Nanotrap Particles enabled the identification of SARS-CoV-2 RNA in 9 out of 32 diagnostic remnant samples that had previously tested negative for the virus. (1)

  • Increase assay sensitivity by capturing and concentrating low abundance viruses. Nanotrap particles improved real-time RT-PCR signal in low viral load diagnostic remnant samples by an average of 3.1 Ct values and sequencing coverage in low viral load diagnostic remnant samples by 20-80%. (1)(2)

  • Successfully utilized in high-complexity and point-of-care RT-PCR assays with FDA Emergency Use Authorization for COVID-19. (3)(4)

  • Available in the Streck® Viral Extraction Kit with CE mark for isolating intact virus particles contained in clinical samples.(5)

bottom of page